Risk factors for treatment failure in women with uncomplicated lower urinary tract infection
| Main Authors: | Romain Martischang, Maciek Godycki-Ćwirko, Anna Kowalczyk, Katarzyna Kosiek, Adi Turjeman, Tanya Babih, Shachaf Shiber, Leonard Leibovici, Elodie von Dach, Stephan Harbarth, Angela Huttner |
|---|---|
| Format: | info dataset Journal |
| Bahasa: | eng |
| Terbitan: |
, 2021
|
| Subjects: | |
| Online Access: |
https://zenodo.org/record/5024262 |
Daftar Isi:
- Origin : This dataset represent a sub-population of a previous clinical trial. Huttner A, Kowalczyk A, Harbarth S, et al.. Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA. 2018;319(17):1781-1789. DOI: 10.1001/jama.2018.3627. Databases : 1st database : women included in the nested cohort study (n=350) 2nd database : women with microbiologically conformed UTI (n=279) 3d database : women with E.coli related UTI (n=185) Important : Data from Tel Aviv have been removed from this dataset, and might be shared by the corresponding author upon reasonable request at the following address (romainmartischang@gmail.com). Codebook : v1_XXX; 0/1 : All symptoms present at baseline v1dipstick : Negative (0), nitrites (1), leukocytes esterase (2), both (3), not done (4) centre : recruitment centre (CHE or POL) rfscore : risk factor for carrying a resistant bacteria as defined in the initial trial treatment : nitrofurantoin (0) vs fosfomycin (1) dm : diabetes mellitus case2 : bacteriological failure at 28 days as defined in the initial trial case1 : clinical failure at 28 days as defined in the initial trial recur14 : bacteriological failure at 14 days as defined in the initial trial fail14 : clinical failure at 14 days as defined in the initial trial v1pathogen[1-3] : pathogen present at baseline